1. Anti-inflammatory and anticancer effects of p-methoxycinnamic acid, an active phenylpropanoid, against 1,2-dimethylhydrazine-induced rat colon carcinogenesis
   Sivagami Gunasekaran et al, 2019, Molecular and Cellular Biochemistry CrossRef
2. Copper-related genes predict prognosis and characteristics of breast cancer
   Yi Liu et al, 2023, Frontiers in Immunology CrossRef
3. Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer
   Matthew Kearney et al, 2021, Breast Cancer Research and Treatment CrossRef
4. Effects of Ruxolitinib and Calcitriol Combination Treatment on Various Molecular Subtypes of Breast Cancer
   Jean Schneider et al, 2022, International Journal of Molecular Sciences CrossRef
5. Combinations of Calcitriol with Anticancer Treatments for Breast Cancer: An Update
   Mariana Segovia-Mendoza et al, 2021, International Journal of Molecular Sciences CrossRef
6. Combined treatment with ruxolitinib and MK-2206 inhibits the JAK2/STAT5 and PI3K/AKT pathways via apoptosis in MDA-MB-231 breast cancer cell line
   Esin Guvenir Celik et al, 2023, Molecular Biology Reports CrossRef
7. Combination therapy of calcitriol inhibits the proliferation of breast cancer cells: new concept of nonclassical function of calcitriol
   Khuzama A. Aljunidee et al, 2022, Hormone Molecular Biology and Clinical Investigation CrossRef
8. Visible Light-Promoted Green and Sustainable Approach for One-Pot Synthesis of 4,4’-(Arylmethylene)bis(1H-pyrazol-5-ols), In Vitro Anticancer Activity, and Molecular Docking with Covid-19 Mpro
   Anamika Gupta et al, 2022, ACS Omega CrossRef